SCHEMBL754466

SCHEMBL754466

CCOC(=O)C1=C(C)C=CCC1(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.39
KDM4E B2RXH2 3/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
ALOX15 P16050 1/20 0.39
TSHR P16473 1/20 0.38
MAPK1 P28482 1/20 0.37
ALDH1A1 P00352 4/20 0.36
HPGD P15428 2/20 0.36
HTT P42858 2/20 0.36
NPSR1 Q6W5P4 2/20 0.36
HSP90AA1 P07900 1/20 0.36
CACNA1B Q00975 1/20 0.36
APBA1 Q02410 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
LMNA P02545 4/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
PKM P14618 1/20 0.36
CCR6 P51684 1/20 0.36
GLA P06280 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25208706 0.84 MAPK1 (0.38) MAPTKDM4EMEN1KMT2AALOX15
SCHEMBL11528099 0.84 MAPT (0.37) MAPTKDM4EMEN1KMT2AALOX15
SCHEMBL25200829 0.82 MAPT (0.38) MAPTKDM4EMEN1KMT2AALOX15
SCHEMBL3642091 0.80 ALDH1A1 (0.38) MAPTKDM4EMEN1KMT2AALOX15
SCHEMBL4366145 0.77 MAOA (0.36) MAOAL3MBTL1
SCHEMBL2912133 0.77 MAOA (0.36) KDM4EALDH1A1GLACYP3A4MAOA
SCHEMBL13966472 0.77 PTGS1 (0.33) ALOX15TSHRALDH1A1HPGDTDP1
SCHEMBL11455467 0.76 MAOA (0.33) MAOA
SCHEMBL2349684 0.75 ALDH1A1 (0.38) MEN1KMT2AALOX15TSHRALDH1A1
SCHEMBL11456625 0.73 MAOA (0.35) MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 548 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12589377-B2 Encapsulated composition comprising core-shell microcapsules and process for its preparation GIVAUDAN SA (CH) 2026-03-31 US claimed
EP-4695016-A1 IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS Givaudan SA (CH) 2026-02-18 EP claimed
EP-4405323-B1 PROCESS FOR PREPARING A CYCLIC DIENE FIRMENICH & CIE (CH) 2026-01-14 EP claimed
EP-4655373-A1 BIODEGRADABLE PERFUME COMPOSITION Givaudan SA (CH) 2025-12-03 EP claimed
US-20250302728-A1 FRAGRANCE COMPOSITIONS AND PRODUCTS CONVEYING A POSITIVE MOOD SYMRISE AG (DE) 2025-10-02 US claimed
US-12404479-B2 Laundry detergent composition containing graft copolymer and benefit agent THE PROCTER & GAMBLE COMPANY (US) 2025-09-02 US claimed
US-20250235136-A1 ORGANIC COMPOUNDS GIVAUDAN SA (CH) 2025-07-24 US claimed
EP-4555060-A1 LAUNDRY DETERGENT COMPOSITION CONTAINING GRAFT COPOLYMER AND BENEFIT AGENT The Procter & Gamble Company (US) 2025-05-21 EP claimed
US-20250129312-A1 CONSUMER PRODUCT COMPOSITIONS WITH PERFUME ENCAPSULATES PROCTER & GAMBLE (US) 2025-04-24 US claimed
EP-4526411-A1 FRAGRANCE COMPOSITIONS AND PRODUCTS CONVEYING A POSITIVE MOOD Symrise AG (DE) 2025-03-26 EP claimed
WO-2006095200-A1 PERFUME COMPOSITIONS QUEST INTERNATIONAL SERVICES B.V. (NL) 2006-09-14 WO claimed
WO-2005103214-A2 PERFUME COMPOSITIONS QUEST INTERNATIONAL SERVICES B.V. (NL) 2005-11-03 WO claimed
US-20050245407-A1 Fragrance composition KAO CORPORATION (JP) 2005-11-03 US claimed
EP-1552814-A1 FRAGRANCE COMPOSITION Kao Corporation (JP) 2005-07-13 EP claimed
US-20040063604-A1 Perfume compositions QUEST INTERNATIONAL B.V. (NL) 2004-04-01 US claimed
EP-1343466-A1 PERFUME COMPOSITIONS QUEST INTERNATIONAL B.V. (NL) 2003-09-17 EP claimed
CN-1361817-A Perfume compositions PROCTER & GAMBLE (US) 2002-07-31 CN claimed
WO-2002049600-A1 PERFUME COMPOSITIONS QUEST INTERNATIONAL B.V. (NL) 2002-06-27 WO claimed
EP-1072673-A2 Perfume compositions THE PROCTER & GAMBLE COMPANY (US) 2001-01-31 EP claimed
WO-2001005919-A2 PERFUME COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2001-01-25 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12589377-B2 Encapsulated composition comprising core-shell microcapsules and process for its preparation CUTA, EXOC1, EXOSC10 MAPT 1016/4885KDM4E 3436/4885MEN1 1693/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.